Seth van Voorhees, CHIEF FINANCIAL OFFICER at NRX Pharmaceuticals, Inc. (NRXP), bought 30,000 shares at $1.10 ($33K) on 2022-12-16, disclosed to the SEC on 2022-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| REFR | BUY | 2017-09-13 | $5K | — | Filing → |
| REFR | BUY | 2014-06-19 | $11K | — | Filing → |
| REFR | BUY | 2011-02-14 | $104K | — | Filing → |